|Year : 2007 | Volume
| Issue : 1 | Page : 17-24
Initiating tumor banking for translational research: MD Anderson and Liverpool experience
A Mishra1, A Pandey2, R Shaw3
1 Department of Otolaryngology at King George's Medical University Lucknow, India and currently a Visiting Faculty and International UICC (American Cancer society) Fellow at the Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, USA
2 Department of Obstetrics and Gynecology, King George's Medical University Lucknow, India
3 Department of Oral and Maxillofacial Surgery, University Hospital Aintree, Liver pool and currently a Visiting Scientist at the Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, USA
Department of Otolaryngology at King George's Medical University Lucknow, India and currently a Visiting Faculty and International UICC (American Cancer society) Fellow at the Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, USA
Source of Support: None, Conflict of Interest: None
The ultimate progress in the cancer diagnosis and therapy has only been possible with the ongoing translational research that is likely to play a very important role in future as well. Hence the importance of such translation from bedside to bench and visa versa cannot be over-emphasized. Accordingly it has become more important to collect tumor samples along with the clinical information in a systematic manner to perform a good basic science research in future. With a population of over a billion and a heavy burden of cancer, India has the 'biggest' potential to establish the 'largest' tumor bank across the globe. Establishing a tumor bank involves money and manpower that may not be feasible across most of the centers in India. Taking into the considering the model of tumor banking of the two leading institutions of the world (MD Anderson Cancer Center, USA and University Hospital Aintree, Liverpool UK), this article presents the salient tips for a center in India to get started with tumor banking with minimal investment. Furthermore a simplified form of ethical consent is presented for the centers to adapt unanimously.
Keywords: Tissue-banking, tumor-banking
|How to cite this article:|
Mishra A, Pandey A, Shaw R. Initiating tumor banking for translational research: MD Anderson and Liverpool experience. Indian J Cancer 2007;44:17-24
Tissue sample of tumors is the most important rate-limiting factor for carrying out any translational research. Such samples need to be properly processed, stored and carefully tagged with its clinical behavior. Hence a cancer research center needs to maintain a proper tissue bank from where serial stored samples along with the relevant clinical records can be obtained for a translational cancer research in future. Till date the concept of tissue banking in India is mainly concentrated in a few major cancer research institutes such as the Tata Memorial Hospital. Most of the cancer centers across the country do not have the concept of tumor banking. With over a billion population and an enormous cancer burden, such a concept would definitely unfold the enormous potential for translational cancer research in India. Considering the existing protocol of tumor banking at MD Anderson Cancer Center (USA) and University Hospital Aintree (Liverpool) we suggest some guidelines to initiate this concept in less well-equipped institutes of India. Ideally it has to be defined beforehand whether such a repository is a freestanding entity, virtual or a part of institution and moreover the standard operating procedures manual (SOPs) should be framed accordingly. Further discussion would highlight our views for starting this the concept as a freestanding entity with meager resources across the country.
| » MD Anderson Cancer Center Protocol|| |
The head and neck tissue banking was started approximately 15 years ago at MD Anderson Cancer Center, Houston Texas and till date the bank has a total collection of approximately 25000 tissue specimen. This subsequently proved to be a model for Central MD Anderson Tissue Bank. The salient features of the protocol are as follows:
- Ethics and consent process: Considering the ethics involved, a proper consent is essential before tissue procurement. A special tissue-procurement-nurse for this purpose visits the wards a day prior to surgery to obtain an open ended 'generic' consent or for specific study protocol.
- Paperwork raised by the nurse is delivered to the staff of both operation theatre and pathology lab for pre-planning the specific medium requirements. In certain situations when preoperative consent is not available, the relevant attending staff is accordingly informed. The consent tissue can then be sought either 'retrospectively' or the tissue destroyed as the case may be.
- As soon as the specimen is removed (biopsy or excision) in the operation theatre, the pathology lab is telephonically informed. The entire specimen is transported to the pathology lab as soon as possible.
- The surgical specimen is examined and further 'cut' as per the size of the specimen. In case of large tumors (>1 cm) a small piece of tumor with normal margins is taken up for research that is subsequently coded and logged. Half is considered for optimum temperature for cutting (OTC) and other half is snap frozen. Research samples are compared to mirror image fixed specimens and thereby pathology checked following H and E examination. The remaining tissue is fixed and examined as normal. Following histopathological assessment, further specimens are retrieved from the paraffin blocks, such that half of the tissue represents the tumor and the other half surrounding 'normal' i.e., the invasive front, dysplasia, involved and uninvolved lymph nodes.
- For small tumors (1 cm or less), no fresh tissue is retrieved in order to prevent damage to margins endangering useful diagnostic tissues. After histopathological assessment, a tumor sample and a normal sample is taken from the fixed specimen.
- Hence for each major tissue excision, the following are available for research: (a) Snap frozen tumor (>1 cm); (b) Snap frozen normal margin (if > 1cm); (c) OTC frozen tumor (>1 cm); (d) OTC frozen normal margin (if > 1 cm); (e) fixed tumor; (f) fixed close margin; (g) fixed normal margin; (h) fixed lymph node; (i) fixed dysplastic mucosa.
- Importantly the time interval between arrival in the pathology lab and freezing is recorded considering its importance in receptor / RNA studies where morphological changes may be important.
- For specific research protocols or clinical trials other procedures are carried out such as snap frozen in operation theatres itself. Ideally the tumor specimen should be frozen within 10 min of surgical resection in order to prevent RNA degradation. The ideal storage place is the liquid nitrogen cylinder. The protocol for human sample processing as carried out at MD Anderson is depicted in [Table - 1].
A comprehensive and dedicated database for each specimen is maintained through intranet and it is planned to link tissue database with clinical database in near future. In order to maintain such a tissue bank, MD Anderson has three regular staff members solely dedicated for this purpose. A research technician carries out coding, database entry processing and storage of specimens and is also trained to prepare DNA, RNA, tissue micro-arrays etc.
| » Developing Tissue Banking in India|| |
A very important technical aspect of concern is the temperature for storing the tissue specimen. Many scientists believe that storing the tissues at lower temperatures helps in preserving the integrity of the biopsy specimen for long-term,, however there is no general consensus on this. Even RNA studies have been performed on paraffin block tissues but the sensitivity decreases with increasing temperature of storage. Hence the more lower the storage-temperature, the better. Ideally the specimen should be preserved in large liquid nitrogen cylinder, which unfortunately may not be available in the majority of centers across the country. In most medical colleges the departments of pathology and surgery are located in different buildings and hence a significant delay occurs in tissue transportation. In such situations it seems ideal to maintain a deep freeze refrigerator for small tissue collections in the respective departments. Several options for storing the tissues in a deep freeze refrigerator as a less expensive methodology can be considered based on UKBTS guidelines. The biopsy tissue must be placed in an ambient temperature of -20oC within 48h of retrieval. This does not only enhance bacteriostasis but is known to facilitate long-term storage for six months. Alternatively if such storage can be maintained at -40oC then long-term storage can be maintained for a period of three years. It is worth mentioning that as per UKBTS guidelines, the tissue if preserved in high concentration glycerol may be stored at 0oC to -10oC for up to two years. Considering the above methods it may be possible to store the tissue in heavy glycerine at -40oC for a very long time. It has been a convention to store tissue at less that -80oC for long term, but considering the practicalities in India, this glycerol-preservation seems to be the best alternative in initiating the process. Such 'compromised tissues' may not be well suited for RNA studies as such. It is not infrequent to have frequent short-time power failures in the absence of uninterrupted power backup in our facility. To withstand this, we suggest the use of cryogel bags around the storage racks inside the freezer to maintain the desired temperature in a 10 degree celsius range as advocated for a prolonged time. However in case of prolonged electrical failure the freezer should be backed-up with a UPS / generator facility. Also adequate backup capacity for low-temperature units must be maintained in anticipation of possible equipment failure. It is desirable to have satisfactory temperature (less than 22 degree Celsius), lighting and sufficient space for air circulation at the place where mechanical freezers are installed. Adequate ventilation is critical in liquid-N2 repositories and where dry ice is used to ensure that sufficient oxygen levels are maintained.
The most important issue in tissue banking is freely given informed patient consent. Tissue banks of human specimens for research must adhere to all central / state government and local regulations. Research on human specimen involves no interaction with patient and the risks are primarily from loss of confidentiality. Accordingly the processes and procedures for storage of human specimens for research should be available for review by an IRB to assure that they are appropriate to protect human subjects. For prospective collection of human biological materials the disclosure should include details of procedures (drawing blood, buccal swab), risks / benefits involved (bruising at site, access to records by others, no prospect of direct benefit) and guarded 'right-to-withdraw' because active participation ends at the time of collection, while sample would remain but links would be destroyed and genetic information would exist in the databases. Consent can be for a specific research use or for future unspecified uses. If the use is unspecified, an IRB review of the research must be conducted to assure that the use is consistent with the original consent. An example of the customized consent form based on a project 'Cytogenetic analysis of oral squamous cell carcinoma'is depicted in [Table - 2]. This has been adapted from the 'University Hospital Aintree, Liverpool' protocol, where such tumor banking has recently been initiated. [Table - 3] depicts a sample of the relevant information necessary to be conveyed to the patient before consenting. Ideally all patient consent forms must be updated annually to be in compliance with IRB regulations.
Another important aspect is maintenance of clinical records and linking it to the specimen. Confidentiality of clinical records needs to be maintained specially in terms of identity of the subject. However the HIPAA 'Privacy rule' 1996 establishes a category of health information referred to as protected health information (PHI) which may be disclosed only under certain conditions. This is with an aim to permit researchers to review PHI in medical records or elsewhere to prepare a research protocol. Such a de-identified data would exclude all the possible subject identifiers and would be released after a non-disclosure agreement by the researcher. The Records need to be retained for a minimum of 10 years after the date of distribution / expiration of sample. Ideally the electronic records should be backed-up regularly on a network or remote server or on a CD / floppy.
The continuance, success and long term utility of a tumor bank depends upon its quality assurance (QA) and intermittent quality control checks. The QA programme of a tissue bank involves planning, implementation, documentation, assessment and improvement to ensure that the processing or specimen / item is of a standard quality. Quality control check on the other hand involves technical activities to measure the attributes and performance of a certain process or item against defined quality standards. It is important for a quality assessment program to maximally adapt to current-good-manufacturing-practices (cGMP)-regulatory guidelines as per its limitations. This would include secured area with limited access, trained personnel for required procedure, provision of internal QA audits by external agents, maintenance of extensive paper trail for all materials and equipments, documentation of equipment maintenance procedures as well as for all events that fall outside SOPs. It is important to note that ISO9001 is another system standard created through the international organization for standardization (ISO). ISO is similar to cGMP, but is more recognizable in international settings. Hence this may not initially suit a small repository of a developing country. All the tumor banks must be subjected to regular audits for example a weekly check of freezer temperature logs and a more complete review on a monthly or quarterly basis that includes random checks of SOPs for expiration and possibly pulling and checking random sets of specimens against the inventory list.
The consideration of safety is of paramount importance for those persons dealing with human samples in tumor banks. Apart from the general safety measures against fire, electrical and physical hazards as applicable elsewhere, special precautions need to be undertaken to protect the employees against blood-borne pathogens and diseases spread through skin-to-skin contact such as scabies and tuberculosis (specially in India). Vaccination against hepatitis should be encouraged. Accordingly every tumor bank should define the safety priorities and thereby develop a comprehensive safety programme in the light of national, state, regional and local regulations for health protection. It is preferable to establish a safety committee for planning, implementing and monitoring overall safety programme through a safety officer, which in turn collaborates with local area supervisors to establish safety-training-programmes. In the absence of such safety committee the legal responsibility of a hazard lies with the person designated or the overall in-charge of the tumor bank. Hence training for all the employees is mandatory in every domain (biohazards, chemical hazards, radiological hazards) and that too should be documented and updated each year. It is very important to note that all human specimens irrespective of state are to be treated as infectious since prions (C-J disease) may still be active with fixed tissues processed to paraffin blocks. Hence the use of apron coats, long pants, covered shoes, plastic gloves, glasses and masks protect the employee from biohazard as well as avoid chemical and thermal burns from both heat and cold (liquid N 2 and dry ice). All chemicals should have material safety data sheets (MSDS) available for reference for employees who potentially will come into contact with these chemicals. MSDS are available from manufacturers. Storage of food / beverages should be strongly prohibited in laboratory areas and the same applies to mouth pipetting / suctioning. After handling potential hazardous material, hands and other exposed skin surfaces need to be thoroughly washed. A written emergency plan should be established to address the prevention, containment, cleanup and waste disposal in case of chemical spills. In general, some basic security systems such as alarms are desirable and a responsible person should take necessary action in a time frame to minimize the damage to collected material / specimen. Electricity safety can be assured by proper grounding of electric equipments, using electrical base plugs in good condition, proper use of fuses and surge-protectors as well as ensuring that water sources (sinks) are away from electrical devices. Fire safety can be ensured by storing flammable agents in fire cabinets, purchasing refrigerators/ freezers that are noncombustible, use of different types of fire-extinguisher-cylinders and strictly prohibiting smoking. Carefully analyzing the work environment and correctly applying ergonomics thereafter can enhance physical safety. This would also significantly reduce the visual and musculoskeletal discomfort. Considering the overall security it is important to limit access of unauthorized personnel in the workplace.
For initiating tumor banking following 'material-protocol' may be adapted:
- The large postoperative surgical specimen soon after excision should be incised with a fresh disposable blade into four pieces with margins. The first piece should be stored in formalin. The second piece should be further subdivided into multiple pieces (1-2 mm) and each sub-piece should be stored separately both in normal saline and heavy glycerine in the deep freezer. The idea is to prevent multiple cycles of freezing and thawing while retrieving a small piece for study. During retrieval of the specimens, the plastic cryovials should be thawed at room temperature, while glass vials should be thawed overnight in a refrigerator to prevent cracking. The third piece should be stored as a paraffin block after histopathological examination and the fourth piece should be reserved for any special research protocols e.g., microbiological assessment for fungal elements etc.
- For a small specimen, one half should be sent for histopathology and the other half retained separately in small aliquots both in normal saline and glycerine in the deep freezer.
- A very small tissue specimen such as that obtained through biopsy should be sent as a whole to pathology lab for paraffin block. With a few millimeters of specimen, tissue banking may be limited to obtaining a paraffin block only but after establishing the diagnosis.
- The other patient samples such as heparinised whole blood, plasma, urine, saliva etc can be stored preferably in deep freezer or alternatively as per the desired protocol. [Table - 1] depicts the processing procedures adapted from MD Anderson Cancer Center. It is important to rinse the pipette-tips with 10% bleach solution before discarding.
The 'linking' of clinical records with the stored specimen through the use of simple Microsoft access software seems to be most appropriate initially. This preliminary level of tumor banking is applicable to most of the medical colleges across India. The training of post-graduate residents for tissue collection, processing, storage and retrieval would be much easier and definitely desirable since with limited resources, it would be difficult to employ separate staff for the tumor bank. This would further minimize the hazards associated with the program. In places where storage in liquid nitrogen cylinders is feasible, it is important to note that the vapor-phase avoids safety hazards inherent in the liquid-phase storage. It may not be possible to bar-code the aliquots and hence appropriate coding for example including the patient's initial, date of collection or some alternate method should be adapted. It is important to use proper labels / stickers and ink to last for at least 10 years.
Certain recently built cancer centers across the country have an advantage that the pathology facility exists in close vicinity to the operating theatres in the same hospital premises. This facilitates the tissue specimen from all the departments to be processed at a single place only, thus reducing the expenses incurred for manpower and equipment, that otherwise need to be maintained at the respective departments. However if the geographic distance is substantial, the postoperative tissue specimen can be temporarily stored for transportation in either small liquid-nitrogen cylinders or a tight thermacol box with frozen cryogel bags. Alternatively if the geographical distance is not much the fresh specimen may be transported in a sterile container on wet ice from surgery to pathology / repository. This still facilitates the concept of tissue processing at only one specific place, thus reducing the additional costs. To adapt the MD Anderson model of tissue banking it is essential to have the following:
- Dedicated manpower / employees for this purpose only. The involvement of post-graduate residents would overcome this limitation in most of the centers across the country.
- A good maintenance of database linking the tissue specific details with clinical details. Defined protocols for filling up the specific details need to be developed in this regard.
The concept of tumor banking at various levels of complexity needs to be incorporated amongst the teaching medical colleges across the country. This would be an asset for future translational studies in terms of tissue access that otherwise may not be feasible (to obtain) from a distant place (say for example virtual tumor bank EORTC data center) due to cost restraints in most of the centers in India. It may not be feasible to carry out all types of translational research in the beginning but after adapting increasing complexities of tumor banking, the stored biological specimens may become sensitive for high quality basic research.
| » Acknowledgment|| |
The work done (main author: AM) has been supported by a UICC American Cancer Society International Fellowship for Beginning Investigators. The author would like to further acknowledge Dr. Adel El-Naggar MD, Professor, Department of Pathology and Dr. GL Clayman MD Professor, Department of Head and Neck Surgery, UT MD Anderson Cancer Center, Houston for their expert inputs.
| » References|| |
|1.||Karlsson JO, Toner M. Long term storage of tissues by cryopreservation: Critical issues. Biomaterials 1996;17:243-56. [PUBMED] [FULLTEXT]|
|2.||Eiseman E, Bloom G, Brower J, Clancy N, Olmstead SS. Case studies of existing human tissue repositories 2003. [Last accessed on 2006 Feb 1]. Available from: http://www.rand.org/pubs/monographs/2004/rand_mg120.sum.pdf. |
|3.||UKBTS Guidelines, Tissue retrieval and processing (chapter 22), Guidelines for the blood transfusion services in the United Kingdom. [Last accessed on 2006 Feb 1]. Available from: http://www.transfusionguidelines.org.uk/uk_guidelines/ukbts6_213.html. |
|4.||Best practices for repositories I: Collection, storage and retrieval of human biological materials for research (ISBR Best Practice Guidelines). Cell Preservation Technology. 2005; 3(1):5-48. [Last accessed on 2007 Feb 15]. Available from: http://www.isber.org/pubs/bestpractices.pdf. |
[Table - 1], [Table - 2], [Table - 3]
|This article has been cited by|
||Effect of Duration of Ex Vivo Ischemia Time and Storage Period on RNA Quality in Biobanked Human Renal Cell Carcinoma Tissue
| ||Hongyan Sun,Ran Sun,Miao Hao,Yuqian Wang,Xuewen Zhang,Ya Liu,Xianling Cong |
| ||Annals of Surgical Oncology. 2015; |
|[Pubmed] | [DOI]|
||Effects of Delay in the Snap Freezing of Colorectal Cancer Tissues on the Quality of DNA and RNA
| ||Sang Hyun Hong, Hyun Ah Baek, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon, Myoung Jae Kang, Dong Geun Lee, Ho Sung Park |
| ||Journal of the Korean Society of Coloproctology. 2010; 26(5): 316 |
|[VIEW] | [DOI]|
||Quality Control Program for Fresh Frozen Tissue and Its Results of Chonbuk National University Hospital National Biobank of Korea
| ||Shin Young Park, Hyun Ah Baek, Hyoung Jong Kwak, Sang Hyun Hong, Ho Sung Park, Kyu Yun Jang, Woo Sung Moon, Myoung Jae Kang, Dong Geun Lee, Myoung Ja Chung |
| ||The Korean Journal of Pathology. 2010; 44(3): 295 |
|[VIEW] | [DOI]|